Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy

Journal of Clinical Sleep Medicine

Volumn 3, Issue 5, 2007, Pages 473-478

  De Haas, Sanne ^a   Otte, Andreas ^b   De Weerd, Al ^c   Van Erp, Gerard ^d   Cohen, Adam ^a   Van Gerven, Joop ^a  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b PFIZER INC   (United States)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

Epilepsy; Placebo controlled; Polysomnography; Pregabalin; Sleep disturbance

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; PLACEBO; PREGABALIN; VALPROIC ACID;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOCAL EPILEPSY; HEADACHE; HUMAN; MALE; MULTICENTER STUDY; POLYSOMNOGRAPHY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REM SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE;

EID: 34548493475     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.26911     Document Type: Article

References (41)

1. de Weerd A, de Haas S, Otte A, et al. Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 2004;45:1397-404.
2. Manocchia M, Keller S, Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res 2001;10:331-45.
3. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22:379-85.
4. Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63:49-55.
5. Bazil CW. Epilepsy and sleep disturbance. Epilepsy Behav. 2003;4 Suppl 2:S39-45.
6. Vaughn BV, D'Cruz OF. Sleep and epilepsy. Semin Neurol. 2004;24:301-13.
7. Manni R, Tartara A. Evaluation of sleepiness in epilepsy. Clin Neurophysiol 2000;111 Suppl 2:S111-4.
8. Besset A. Influence of generalized seizures on sleep organization. In: Sterman MB, Shouse MN, Passouant P, eds. Sleep and epilepsy. New York: Academic Press;1982:339-46.
9. Touchon J, Baldy-Moulinier M, Billiard M, Besset A, Cadhillac J. Sleep organization and epilepsy. Epilepsy Res 1991;2:73-81.
10. Crespel A, Baldy-Moulinier M, Coubes P. The relationship between sleep and epilepsy in frontal and temporal lobe epilepsies: practical and physiopathologic considerations. Epilepsia 1998;39:150-7.
11. Harden CL. The co-morbidity of depression and epilepsy: Epidemiology, etiology, and treatment. Neurology 2002;59:48-55.
12. Vaughn B. Differential diagnosis of paroxysmal nocturnal events in adults. Bazil CW, Malow BA, Sammaritano MR, eds. Sleep and epilepsy: the clinical spectrum. Amsterdam: Elsevier Science B.V., 2002:325-338.
13. Bazil C. Sleep and epilepsy. Curr Opin Neurol 2000;13:171-5.
14. Sammaritano M, Sherwin A. Effect of anticonvulsants on sleep. Neurology 2000;54:S16-S24.
15. Legros B, Bazil CW. Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Med. 2003;4:51-5.
16. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: The calcium channel alpha2-delta subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007;73:137-50.
17. French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003;60:1631-7.
18. Arroyo S, Anhut H, Kugler AR, et al. Pregabalin 1008-011 International Study Group. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004;45:20-7.
19. Brodie MJ. Pregabalin as adjunctive therapy for partial seizures. Epilepsia 2004;45 Suppl 6:19-27.
20. Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA. Pregabalin 1008-009 Study Group. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005;64:475-80.
21. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-83.
22. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004;110:628-38.
23. Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004;109:26-35.
24. Jaffe M, Iacobelis D, Young JP et al. Post-hoc results show beneficial effects of pregabalin in patients with osteoarthritis of the hip. Poster presented at American College of Rheumatology, in Philadelphia, Pennsylvania, USA, October 28 - November 2, 2000.
25. Hindmarch I, Dawson J, Stanley N. A double blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 2005;28:187-93.
26. Commission on Classification and Terminology of the International League Against Epilepsy (ILEA). Proposal for revised clinical and clectroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:489-501.
27. Sweere Y, Kerkhof GA, de Weerd AW, Kamphuisen HA, Kemp B, Schimsheimer RJ. The Sleep Diagnosis List (SDL): a questionnaire for screening general sleep disorders. Sleep-Wake Research in the Netherlands 1998;9:117-21.
28. Sweere Y, Kerkhof GA, De Weerd AW, Kamphuisen HA, Kemp B, Schimsheimer RJ. The validity of the Dutch Sleep Disorders Questionnaire (SDQ). J Psychosom Res 1998;45:549-55.
29. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. US Department of Health, Education, and Welfare, Public Health Service, Washington DC; US Government Printing Office. 1968
30. Hayes RD, Stewart AL. Sleep measures. In: Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being. Durham, NC: Duke U Press, 1992.
31. Mulder-Hajonides van der Meulen WREH, Wijnberg, JR, Hollander JJ, de Diana LPF, van den Hoofdakker RH. Measurement of subjective sleep quality. Eur Sleep Res Soc Abstr 1980;5:98
32. Meijman TF, Thunnissen MJ, de Vries-Griever AGH. The after-effects of a prolonged period of day-sleep on subjective sleep quality. Work Stress 1990;4:65-70
33. Verhelst MMR, Kerkhof GA, Schimsheimer RJ, Kemp B, de Weerd A. Objective sleep quality versus subjective sleep quality in 332 patients. J Sleep Res 2000;9:200.
34. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005;6:41-4.
35. Leppamaki S, Meesters Y, Haukka J, Lonnqvist J, Partonen T. Effect of simulated dawn on quality of sleep-a community-based trial. BMC Psychiatry 2003;3:14.
36. Buysse DJ, Monk TH, Carrier J, Begley A. Circadian patterns of sleep, sleepiness, and performance in older and younger adults. Sleep 2005;28:1365-76
37. Cicolin A, Magliola U, Giordano A, Terreni A, Bucca C, Mutani R. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers. Epilepsia 2006;47:82-5
38. Goel N, Kim H, Lao RP. Gender differences in polysomnographic sleep in young healthy sleepers. Chronobiol Int 2005;22:905-15.
39. Placidi F, Scalise A, Marciani MG, Romigi A, Diomedi M, Gigli GL. Effect of antiepileptic drugs on sleep. Clin Neurophysiol 2000;111:S115-9.
40. Manni R, Galimberti CA, Sartori I, Politini L, Murelli R, Tartara A. Nocturnal partial seizures and arousals/awakenings from sleep: an ambulatory EEG study. Funct Neurol 1997;12:107-11.
41. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73.